Clin2
NCT07772453Possibly a fitNot yet recruiting

Iron infusions for anemia after stomach cancer surgery

Gastric Cancer (GC)Iron Deficiency Anemia (IDA)Post-Operative AnemiaRadical Gastrectomy

Treatments studied

Part of Blood & lymphatic, Cancer, Digestive system, Hormones & metabolism clinical trials.

This trial compares two types of iron given through a vein to treat anemia (low red blood cells) after surgery for stomach cancer. It aims to find which treatment is more effective at improving your blood count and energy levels.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
160 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old and weigh at least 50 kg
  • You have had surgery to remove stomach cancer and now have low blood counts (anemia)
  • Your iron levels are low, as confirmed by a blood test
  • You are generally able to care for yourself (ECOG score 0-2)
  • Your liver, kidneys, and blood clotting are working well enough
  • You have not taken iron pills, iron infusions, or erythropoietin in the last 3 months

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04168346Not yet recruiting· Phase 4
IV iron before stomach cancer surgery

This trial tests whether giving iron through a vein before surgery helps people with stomach (gastric) cancer who need an operation. It may be aimed at improving iron levels around the time of gastrectomy (stomach removal).

NCT05407987Recruiting· Phase 3
Iron infusion to improve recovery after gynecologic cancer surgery

This Phase 3 study tests whether giving a specific iron medicine before major gynecologic cancer surgery can improve recovery. It’s mainly for people with low blood counts from low iron stores before surgery.

Calgary, Alberta
NCT05226169Recruiting· Phase 3
Iron medicine plus standard therapy for advanced stomach cancer

This Phase 3 study tests whether giving ferric carboxymaltose (an IV iron treatment) helps people with advanced stomach or stomach–esophagus cancer and iron-deficiency anemia. The goal is to improve safety and how well the standard first-line cancer treatment works.

Seoul
NCT05800600Recruiting· Phase 2
Iron treatment to lower anemia during pre-surgery chemotherapy

This trial tests whether giving iron (iron sucrose) can reduce anemia during chemotherapy before curative surgery. It may help you feel better and have smoother treatment by improving low blood counts caused by iron deficiency.

Philadelphia, Pennsylvania
NCT04913649Recruiting· Phase 4
IV iron for anemia after heart surgery in older adults

This trial tests whether giving iron through a vein after heart surgery helps treat postoperative anemia (low red blood cells) in people age 70 and older. It may improve recovery by correcting low iron levels after surgery.

Breda
NCT05744219Recruiting· Phase 3
Iron after major abdominal surgery to improve recovery

This Phase 3 study tests whether giving iron (as ferric carboxymaltose) after complex major surgery can improve recovery by helping your body rebuild blood and oxygen levels after blood loss. It may help patients who are having certain types of aortic, liver, or pancreas operations.

Uppsala, Sverige

Hear when a new Gastric Cancer (GC) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.